Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo

Journal of the American Academy of Dermatology

Volumn 71, Issue 6, 2014, Pages 1110-1116

  Paradisi, Andrea ^a   Tabolli, Stefano ^a   Didona, Biagio ^a   Sobrino, Luciano ^a   Russo, Nicoletta ^a   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

cutaneous melanoma; nonmelanoma skin cancer; vitiligo

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MELANOMA; NARROW BAND IMAGING; NON MELANOMA SKIN CANCER; PHOTOTHERAPY; PRIORITY JOURNAL; RISK FACTOR; ULTRAVIOLET B RADIATION; VASCULAR SURGERY; VITILIGO; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; SKIN NEOPLASMS; STATISTICAL MODEL;

PHOTOSENSITIZING AGENT; PSORALEN;

ADULT; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FICUSIN; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOTOSENSITIZING AGENTS; RISK; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 84925223877     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.07.050     Document Type: Article

References (30)

1. A. Taïeb, and M. Picardo Clinical practice: vitiligo N Engl J Med 360 2009 160 169
2. G.S. Ogg, P. Rod Dunbar, P. Romero, J.L. Chen, and V. Cerundolo High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo J Exp Med 188 1998 1203 1208
3. K. Ongenae, N. VenGeel, and J.M. Naeyaert Evidence for an autoimmune pathogenesis of vitiligo Pigment Cell Res 16 2003 90 100
4. B. Palermo, R. Campanelli, S. Garbelli, S. Mantovani, E. Lantelme, and V. Brazzelli Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo J Invest Dermatol 117 2001 326 332
5. J.G. van den Boorn, D. Konijnenberg, T.A. Dellemijn, J.P. van der Veen, J.D. Bos, and C.J. Melief Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients J Invest Dermatol 129 2009 2220 2232
6. Y. Jin, S.A. Birlea, P.R. Fain, K. Gowan, S.L. Riccardi, and P.J. Holland Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo N Engl J Med 362 2010 1686 1697
7. D.T. Bishop, F. Demenais, M.M. Iles, M. Harland, J.C. Taylor, and E. Corda Genome-wide association study identifies three loci associated with melanoma risk Nat Genet 41 2009 920 925
8. K.U. Schallreuter, D.J. Tobin, and A. Panske Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo Dermatology 204 2002 194 201
9. C.L. Hexsel, M.J. Eide, C.C. Johnson, R. Krajenta, G. Jacobsen, and I. Hamzavi Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo J Am Acad Dermatol 60 2009 929 933
10. H.E. Teulings, M. Overkamp, E. Ceylan, L. Nieuweboer-Krobotova, J.D. Bos, and T. Nijsten Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners Br J Dermatol 168 2013 162 171
11. L. Gordis Epidemiology 3rd ed. 2004 Elsevier Saunders Philadelphia (PA)
12. N. Balato, L. Di Costanzo, A. Balato, C. Patruno, M. Scalvenzi, and F. Ayala Psoriasis and melanocytic nevi: does the first confer a protective role against melanocyte progression to nevi? Br J Dermatol 164 2011 1262 1270
13. I. Synnerstad, M. Fredrikson, A. Ternesten-Bratel, and I. Rosdahl Low risk of melanoma in patients with atopic dermatitis J Eur Acad Dermatol Venereol 22 2008 1423 1428
14. M. Szklo, and F.J. Nieto Epidemiology: beyond the basics 2nd ed. 2007 Jones and Bartlett Publishers Sudbury (MA) 93 99
15. Stata Corp Stata statistical software, Version 9 2010 StataCorp LP College Station (TX)
16. A.G. Dean, J.A. Dean, D. Coulombier, K.A. Brendel, D.C. Smith, and A.H. Burton Epi Info, Version 6.04b: a word processing, database, and statistics program for epidemiology on micro-computers 1994 Centers for Disease Control and Prevention Atlanta, Georgia
17. H. Gogas, J. Ioannovich, U. Dafni, C. Stavropoulou-Giokas, K. Frangia, and D. Tsoutsos Prognostic significance of autoimmunity during treatment of melanoma with interferon N Engl J Med 354 2006 709 718
18. D.P. Lookingbill, G.L. Lookingbill, and B. Leppard Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program J Am Acad Dermatol 32 1995 653 658
19. E. Calanchini-Postizzi, and E. Frenk Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin Dermatologica 174 1987 266 271
20. C.L. Xexsel, S.D. Bangert, A.A. Hebert, and H.W. Lim Current sunscreen issues: 2007 Food and Drug Administration sunscreen labeling recommendations and combination sunscreen/insect repellent products J Am Acad Dermatol 58 2008 316 323
21. M.M. Salem, M. Shalbaf, N.C. Gibbons, B. Chavan, J.M. Thornton, and K.U. Schallreuter Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage FASEB J 23 2009 3790 3807
22. K.U. Schallreuter, S. Behrens-Williams, T.P. Khaliq, S.M. Picksley, E.M. Peters, and L.K. Marles Increased epidermal functioning wild-type p53 expression in vitiligo Exp Dermatol 12 2003 268 277
23. A. Feily, and N. Pazyar Why vitiligo is associated with fewer risk of skin cancer: providing a molecular mechanism Arch Dermatol Res 303 2001 623 624
24. J.L. Lim, and R.S. Stern High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients J Invest Dermatol 124 2005 505 513
25. R.S. Stern The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study J Am Acad Dermatol 66 2012 553 562
26. R.S. Stern Malignant melanoma in patients treated for psoriasis with PUVA Photodermatol Photoimmunol Photomed 15 1999 37 38
27. R.M. Halder, E.F. Battle, and E.M. Smith Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo Arch Dermatol 131 1995 734 735
28. I.L. Wildfang, F.K. Jacobsen, and K. Thestrup-Pedersen PUVA treatment of vitiligo: a retrospective study of 59 patients Acta Derm Venereol 72 1992 305 306
29. K.K. Park, J.E. Murase, and J. Koo Long-term prognosis of vitiligo patients on narrowband UVB phototherapy J Am Acad Dermatol 66 2012 326 327
30. A. Paradisi, and D. Abeni Clustering of cutaneous melanoma in health-care workers of a dermatological day-hospital unit Dermatology 228 2014 281 284